Our mission is to provide innovative new treatments to cancer patients. These treatments are based on immunomodulatory drugs and the induction of immune responses against tumor-associated antigens.
Immunomodulation Regimen for Advanced Cancer Patients
Active Immunotherapy for Advanced Cancer Patients
Evaluation of the Immune Response in Cancer and Premalignant Lesions:
1. Naturally Ocuring Immune Responses in Premalignant Lesions and High Risk Patients
2. Naturally Ocuring Immune Responses in Cancer Patients